A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis

Non-randomised trial OA: bronze CC0 ⤵ 35 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study compared the efficacy of a gonadotropin-releasing hormone agonist to a continuous oral contraceptive pill for treating bladder endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A prospective comparative clinical trial was done in a tertiary referral center for the treatment of endometriosis in 10 patients with bladder detrusor endometriosis: five were treated with a continuous oral contraceptive (OC) and another five with a GnRH agonist. Continuous OC therapy may be effective in the short-term treatment of bladder endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosisbladder_endometriosis

MeSH descriptors

Contraceptives, Oral Endometriosis Gonadotropin-Releasing Hormone Urinary Bladder Urinary Bladder Diseases Contraceptives, Oral Contraceptives, Oral Endometriosis Endometriosis Endometriosis Female Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Humans Prospective Studies Prospective Studies Time Factors Time Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (2)

Cited by (33)

Source provenance

europepmc
last seen: 2026-10-27T06:12:01.810347+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:05:01.267406+00:00
License: CC0 · commercial use OK